Medical treatments based on anamorelin

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10894041
APP PUB NO 20190175574A1
SERIAL NO

16275669

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods of treating cancer related conditions using anamorelin are described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HELSINN HEALTHCARE SA6912 LUGANO-PAZZALLO

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Allen, Suzan Georgetown, US 5 1
Baroni, Enrico Cernobbio, IT 5 1
Duus, Elizabeth Cape Coral, US 6 1
Friend, John Colts Neck, US 32 2797
Giorgino, Ruben Allschwil, CH 8 2
Lu, Ming Plainsboro, US 151 1917
Mann, William Hoboken, US 5 1
Polvino, William Tinton Falls, US 5 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jul 19, 2024
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 19, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 19, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00